Identification of Early Markers for ALS

Abroad (travel likely)Recruiting

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU Tours, Tours, France, France
Contact: Study coordinator (Philippe Corcia, Pr) · philippe.corcia@univ-tours.fr
Contact: Principal Investigator (Philippe Corcia, Pr)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Biomarkers of Synaptic Damage in Multiple Sclerosis

Multiple Sclerosis · Parkinson Disease · Amyotrophic Lateral Sclerosis

Abroad (travel likely)Recruiting

Pozzilli, Italy

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

Amyotrophic Lateral Sclerosis (ALS)

Abroad (travel likely)RecruitingPHASE2

Scottsdale, United States · La Jolla, United States

A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Abroad (travel likely)RecruitingPHASE1

La Jolla, United States · Palo Alto, United States

Neurologic Stem Cell Treatment Study

Neurologic Disorders · Nervous System Diseases · Neurodegenerative Diseases

Abroad (travel likely)Recruiting

Westport, United States · Coral Springs, United States